LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Judge Edward Davila postponed sentencing for at least one month to consider new evidence of possible government misconduct.
Learn more about the legal remedies potentially available to clinical labs who have not been fully paid for COVID testing by insurers.
Learn about how the COVID-19 pandemic has shaped the clinical lab industry and how those lessons can lead to better labs for the future.
In addition to the prison sentence for the x-ray-related fraud scheme, the company president must also pay nearly $2 million in restitution.
A significant new court ruling from a Minnesota federal court draws a line on how far labs can go when insurers short-change them.
Recent study provides new details on how COVID-19 impacted cancer deaths in the US early in the pandemic and which groups were most affected.
The developer of NGS-based companion diagnostics targets the growing neurology biomarker market.
Pathologist Rajesh C. Dash, MD, discusses the state of AI and digital pathology, as well as challenges and possible solutions.
Two lab staffing experts weigh in on current trends and what labs need to do to attract and retain talent in today’s environment.
Follow the steps in this form to help you develop and implement an effective healthcare equity plan for your lab.